Introduction
Platelets play a key role in the hemostatic response to vascular injury by rapidly accumulating to form a platelet plug. Excessive platelet accumulation and activation at sites of plaque rupture, however, can contribute to arterial thrombotic events, such as stroke and myocardial infarction. Co-activation of adherent platelets by soluble agonists, such as thrombin, and extracellular matrix components, such as collagen, results in dramatic changes in platelet structure and function. Activated platelets undergo shape change, 1 granule release, 2 and a conformational change in the fibrinogen receptor α IIb β 3 that results in aggregation. 3 In a subset of activated platelets, a regulated membrane rearrangement occurs that results in phosphatidylserine externalization, 4 microparticle release, 5 and the surface retention of high levels of fibrinogen and other alpha granule proteins. 6 Although platelets are anucleate, certain cellular aspects of the platelet activation response resemble processes that occur during cell death in nucleated cells. This process has been referred to as "platelet apoptosis". 7 Phosphatidylserine externalization occurs both on activated platelets and apoptotic cells, and platelet microparticle release resembles the membrane fragmentation that occurs in necrotic cells. 8 It is not known, however, if the cellular mechanisms responsible for these events are shared between platelets and nucleated cells.
The mitochondrial permeability transition pore (MPTP) is a non-selective multiprotein pore that spans the inner and outer mitochondrial membranes. Formation of the MPTP plays a critical role in the regulation of some forms of cell death. 9 Deletion of the MPTP regulator cyclophilin D (CypD), causes marked impairment of MPTP formation. [10] [11] [12] [13] In contrast to the effects of CypD's absence on MPTP formation, neither only.
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A rapid loss of mitochondrial transmembrane potential (∆Ψ m ), one of the consequences of MPTP formation, has been demonstrated in some subpopulations of activated platelets, 7, 14, 15 but CypD's role in platelet activation and the hemostatic consequences of platelet MPTP formation have not been investigated. In this study, we tested the hypothesis that MPTP formation and CypD regulate platelet activation and thrombosis.
Materials and methods

Mice
Animal protocols were approved by the University of Iowa and Veterans Affairs Animal
Care and Use Committees. All mice were housed in pathogen-free conditions at the University of Iowa Animal Care Facility under National Institutes of Health guidelines and approved animal care protocols. C57BL/6 mice were obtained from The Jackson Laboratory (Bar Harbor, ME). CypD -/-mice, which are homozygous for a targeted deletion of the Ppif gene, 10 and control CypD +/+ mice were generated as described previously and maintained on an inbred SV129 background. Age and sex-matched mice were used for each experiment.
Platelet isolation
Washed platelets were isolated as described previously. 16 Platelet counts were measured using a HemaVet cell counter (Drew Scientific, Oxford, CT). 
Flow cytometry
Platelet procoagulant activity
Platelet procoagulant activity was measured in a prothrombinase assay as described previously.
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Electron microscopy
Activation of fibrinogen-adherent platelets was performed using a method modified from Leo et al. 18 Glass coverslips (12 mm) were incubated overnight at 4°C in 100 µ g/mL human fibrinogen (Sigma, St. Louis, MO), 150 mM NaCl, 50 mM NaH 2 PO 4 , and 20 mM Na 2 HPO 4 , pH 8.0. After removal of the fibrinogen solution, the coverslips were blocked with 5 mg/mL BSA in PBS for two hours. Following removal of the blocking reagent, washed murine platelets (10 7 /mL) in modified Tyrode's were allowed to adhere for 30 minutes at 37°C. Non-adherent platelets were removed, and the adherent platelets were stimulated with either thrombin (0.5 U/mL), or thrombin (0.1 U/mL) plus convulxin (50 ng/mL) in modified Tyrode's buffer with 2.1mM CaCl 2 . Two minutes following stimulation, the platelets were fixed with gluteraldehyde. The coverslips were prepared for scanning electron microscopy and imaged with a Hitachi S-4800 field emission scanning electron microscope. The images were taken at room temperature, with an integrated digital image capture within the Hitachi S-4800 and acquired with the PC based SEM software by Hitachi S-480.
For transmission electron microscopy, platelets were fixed in a similar manner, sectioned, and imaged using a JEOL JEM-1230 Transmission Electron Microscope.
Platelets were either unstimulated or examined following stimulation with thrombin plus convulxin for two minutes.
Platelet aggregation
only.
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Clot retraction
Clot retraction was performed using a method modified from Schoenwalder et al. 
Tail transection bleeding time
Tails of anesthetized 6-8 week old mice were clipped 3 mm from the distal end and placed in 37°C normal saline for ten minutes. The time to cessation of bleeding and any rebleeding were recorded.
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Carotid artery thrombosis
Carotid artery thrombosis was induced in mice at 3 months of age by photochemical injury as described previously. 21 Blood flow was monitored continuously for 90 minutes or until stable occlusion occurred, at which time the experiment was terminated. No significant differences in baseline carotid artery blood flow were observed between CypD +/+ and CypD -/-mice (data not shown). First occlusion was defined as the time at which blood flow first decreased to zero for at least 10 seconds, and stable occlusion was defined as the time at which blood flow remained absent for 10 minutes or longer.
Statistical analysis
2-way analysis of variance (ANOVA) with the Tukey test for multiple comparisons was The calcium ionophore ionomcyin is a potent activator of platelet phosphatidylserine externalization. 4 Following ionomcyin stimulation, phosphatidylserine externalization was markedly increased in CypD +/+ and CypD -/-platelets ( Figure 3A ).
High-level fibrinogen retention was not increased in either CypD +/+ or CypD -/-platelets following stimulation with ionomycin ( Figure 3B ) consistent with previous reports.
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Vesiculation and blebbing of fibrinogen-adherent platelets are impaired in the absence of CypD
To determine if CypD is essential for platelet shape change or membrane vesiculation, CypD +/+ or CypD -/-platelets were allowed to adhere to fibrinogen, and then stimulated with thrombin or thrombin plus convulxin. Two minutes after stimulation with thrombin, fibrinogen-adherent CypD +/+ platelets had a spread appearance with peripheral flattening, lamellipodia, and filopodial extensions ( Figure 4A ). The appearance of thrombin-stimulated CypD -/-platelets was similar to that of CypD +/+ platelets ( Figure 4B ). After stimulation with thrombin plus convulxin, the majority of Platelet mitochondria from CypD +/+ and CypD -/-platelets at baseline and after stimulation with thrombin and convulxin, did not appear structurally different and had no evidence of swelling when examined in cross-section using transmission electron microscopy (data not shown).
Platelet activation responses are modulated by H 2 O 2
In nucleated cells, reactive oxygen species (ROS), such as H 2 O 2 , can trigger MPTP formation and cell death pathways.
10,12,25-27 Therefore, we examined the effects of For 
CypD -/-platelets have impaired platelet procoagulant activity
Since phosphatidylserine externalization is closely related to platelet procoagulant activity, we examined the ability of activated CypD +/+ and CypD -/-platelets to support thrombin generation by the prothrombinase complex. 4 Activation of CypD +/+ platelets with thrombin plus convulxin, or thrombin plus H 2 O 2 , resulted in a marked increase in platelet prothrombinase activity relative to that observed after activation with thrombin alone (p<0.001) ( Figure 6A ). A smaller increase in platelet prothrombinase activity was observed when CypD +/+ platelets were stimulated with convulxin alone (p<0.01). In contrast, CypD -/-platelets failed to support prothrombinase activity in response to any of the agonist(s) tested ( Figure 6A ).
Clot retraction is altered in the absence of CypD
To begin to investigate the functional significance of antigenic modulation of α IIb β 3 , we examined the aggregation and clot retraction responses of CypD +/+ and CypD -/-platelets. Platelet aggregation occurred in less than 2 minutes using either CypD +/+ and CypD -/-platelets. No differences in the rate or amplitude of the aggregation response were observed between CypD +/+ and CypD -/-platelets stimulated with thrombin or thrombin plus convulxin (data not shown).
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Next, we examined clot retraction using diluted platelet-rich plasma obtained from either CypD +/+ or CypD -/-mice ( Figure 6B and 6C ). No differences in clot retraction were observed between CypD +/+ and CypD -/-mice plasma when clot formation was initiated by either thrombin alone or convulxin alone. After stimulation with thrombin plus convulxin, clot retraction was markedly attenuated in CypD +/+ plasma (p<0.001), but not in CypD -/-plasma. Clot volume was 2-fold lower in CypD -/-plasma than in CypD +/+ plasma after stimulation with thrombin plus convulxin (p=0.001) ( Figure 6C ). This result suggests a functional role for a CypD-dependent process in the regulation of clot retraction.
In vivo hemostasis and thrombosis in CypD -/-mice
Tail transection bleeding times were measured in CypD +/+ and CypD -/-mice. No significant differences in the time to cessation of bleeding ( Figure 6A) were observed.
Next, we compared the thrombotic responses of CypD +/+ and CypD -/-mice using an experimental model of carotid artery thrombosis induced by photochemical injury ( Figure   7B , C). The development of a stable occlusive thrombus occurred more rapidly in CypD -/-mice (16 ± 2 minutes) than in CypD +/+ mice (32 ± 7 minutes) (p<0.05). A trend toward a decreased time to first occlusion also was observed in CypD -/-mice (10 ± 2 minutes) compared with CypD +/+ mice (19 ± 4 minutes) (p = 0.06).
Discussion
In this study, we have demonstrated a critical role for CypD in the regulation of Our results suggest a model in which MPTP formation plays a critical role in the regulation of the transition of a platelet from an "activated" to a "highly-activated" state only.
For personal use at PENN STATE UNIVERSITY on February 21, 2013. bloodjournal.hematologylibrary.org From (Figure 8 ). This transition is regulated by both the quantity and type of agonists(s) present. In response to a weak or moderate stimulus, such as a low concentration of thrombin, MPTP formation does not occur, and the stimulated platelet exhibits a CypDindependent "activated" phenotype. This activated phenotype is characterized by granule release, inside-out activation of To begin to assess the functional significance of CypD-dependent platelet activation responses, we examined the effect of CypD-deficiency on platelet procoagulant activity ( Figure 6A ). In the absence of CypD, platelet prothrombinase activity was markedly impaired. This finding is consistent with the observed decrease in phosphatidylserine externalization and α-granule protein retention of CypD -/-platelets, both of which have been proposed to facilitate prothrombinase complex assembly on the surface of activated platelets. 4, 6 We also examined the effects of dual-agonist stimulation and CypD deficiency on with thrombin plus the calcium ionophore A23187, a condition that strongly favors highlyactivated platelet formation. 24 It is possible, however, that other CypD-dependent events may also contribute to the attenuation of clot retraction observed in the presence of dual agonists. Since MPTP formation disrupts ATP production by oxidative phosphorylation, 9 a decrease in mitochondrial ATP production in highly activated platelets may impede the energy-dependent process of clot retraction. 43 only.
In a model of carotid-artery photochemical injury, we found that thrombosis occurred more rapidly in CypD -/-mice than in CypD +/+ mice. We have considered several potential explanations for this observation. First, since CypD is expressed in multiple tissues, [10] [11] [12] [13] only.
